Harrow, Inc. is a leading ophthalmic disease management company in North America, providing FDA-approved branded pharmaceuticals and compounded medications to eyecare professionals. Its portfolio includes IHEEZO, VEVYE, TRIESENCE, BYOOVIZ, OPUVIZ, BYQLOVI, and over 15 other branded ophthalmic products treating conditions such as dry eye, wet AMD, cataracts, glaucoma, and bacterial infections. Its ImprimisRx subsidiary operates 503A and 503B compounding facilities in New Jersey, serving over 10,000 U.S. eyecare prescribers.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001493152-26-008562 | EDGAR | 77K words |
| 2025-03-27 | 2024-12-31 | 0001641172-25-000925 | EDGAR | 84K words |
| 2024-03-19 | 2023-12-31 | 0001493152-24-010518 | EDGAR | 83K words |
| 2023-03-23 | 2022-12-31 | 0001493152-23-008718 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001493152-22-006525 | EDGAR | — |
| 2021-03-08 | 2020-12-31 | 0001493152-21-005583 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001493152-20-003862 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001493152-19-003188 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001493152-18-003095 | EDGAR | — |
| 2017-03-21 | 2016-12-31 | 0001493152-17-002687 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001628280-26-055271 | EDGAR | 14K words |
| 2025-11-10 | 2025-09-30 | 0001493152-25-021562 | EDGAR | 32K words |
| 2025-08-11 | 2025-06-30 | 0001641172-25-022980 | EDGAR | 29K words |
| 2025-05-08 | 2025-03-31 | 0001641172-25-009263 | EDGAR | 23K words |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045295 | EDGAR | 84K words |
| 2024-08-07 | 2024-06-30 | 0001493152-24-030575 | EDGAR | 23K words |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018902 | EDGAR | 21K words |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040563 | EDGAR | 32K words |
| 2023-08-09 | 2023-06-30 | 0001493152-23-027361 | EDGAR | 84K words |
| 2023-05-11 | 2023-03-31 | 0001493152-23-016414 | EDGAR | 75K words |
| 2022-11-14 | 2022-09-30 | 0001493152-22-032076 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001493152-22-021769 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-04 | 0001493152-26-041569 | EDGAR | 1K words |
| 2026-08-10 | 0001493152-26-036865 | EDGAR | 9K words |
| 2026-08-06 | 0001493152-26-036256 | EDGAR | 2K words |
| 2026-03-27 | 0001493152-26-013199 | EDGAR | 18K words |
| 2026-03-24 | 0001493152-26-012389 | EDGAR | 1K words |
| 2026-03-24 | 0001493152-26-012279 | EDGAR | 1K words |
| 2026-03-10 | 0001493152-26-009452 | EDGAR | 0K words |
| 2026-03-02 | 0001493152-26-008552 | EDGAR | 8K words |
| 2026-02-02 | 0001493152-26-004635 | EDGAR | 2K words |
| 2025-11-18 | 0001493152-25-023988 | EDGAR | 2K words |
388 total filings indexed. 356 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001360214 |
| Ticker | HROW |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.harrow.com |
| Listed | 2007-04-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HROW (~200 tokens, structured JSON with cryptographic provenance)